Has Rohan Kapoor, MD received payments from drug or device companies?

Yes. Drug and device makers reported $17,402 in general payments to Rohan Kapoor, MD across 327 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rohan Kapoor, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rohan Kapoor, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rohan Kapoor, MD

Pain Medicine · Schaumburg, ILNPI 1508275181

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $13,312 of the $17,402 with a category attached, or 76.5%. It is spread thinly across 44 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $6,751, 5.0 times the $1,349 reported in 2019.

$17,402in general payments, 2019–2025

Across 327 payments — averaging $53.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$4K
Nevro Corp.$4K
Medtronic$4K
Globus Medical$2K
AbbVie$594
Collegium Pharmaceutical, Inc.$487
plus $3K from 38 others

What the payments were for

Travel & lodging$4,09124%
Food & beverage$13,31276%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	53	$3,809
Nevro Corp.	50	$3,755
Medtronic(2 entities)	41	$3,680
Globus Medical	15	$1,841
AbbVie(2 entities)	29	$594
Collegium Pharmaceutical, Inc.	29	$487
Abbott	6	$375
Foundation Fusion Solutions, LLC	7	$333
Vertos Medical, Inc.	3	$294
Amgen	9	$286
Lilly USA, LLC	8	$198
GRT US Holding, Inc.	2	$151
Pfizer	7	$142
Fidia Pharma USA Inc.	6	$127
Biodelivery Sciences International, Inc.	9	$124
SPR Therapeutics, Inc	2	$117
Si-bone, Inc.	2	$116
Nalu Medical, Inc.	4	$66
IBSA Pharma Inc.	4	$60
Pacira Pharmaceuticals Incorporated	2	$59
Saluda Medical Americas, Inc.	2	$57
Bioventus LLC	2	$55
Merz Pharmaceuticals, LLC	2	$52
Avanos Medical	2	$51
Spinal Simplicity, LLC	2	$50
Supernus Pharmaceuticals, Inc.	2	$48
Vertex	2	$48
Kowa Pharmaceuticals America, Inc.	3	$43
Ipsen Biopharmaceuticals, Inc	2	$39
Almatica Pharma LLC	2	$37
Currax Pharmaceuticals LLC	2	$34
Johnson & Johnson	2	$33
Valinor Pharma, LLC	2	$31
USWM, LLC	2	$30
Neuros Medical, Inc.	1	$26
Azurity Pharmaceuticals, Inc.	1	$22
Stratus Medical, LLC	1	$20
Painteq LLC	1	$19
Orthofix Medical, Inc.	1	$19
Genentech USA, Inc.	1	$17
Scilex Pharmaceuticals Inc.	1	$16
Pacira Therapeutics, Inc.	1	$16
Teva Pharmaceuticals USA, Inc.	1	$15
Merit Medical Systems Inc	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,402 in reported general payments places this provider in the 85th percentile of 233 pain medicine providers in Illinois.

See all pain medicine providers in Illinois →

Medicare billing

Part B allowed, 2024

$602,340

Medicare patients

671

Services billed

14,935

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	203	$2,080
Pregabalin	16	$1,254
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	17	$641
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	31	$621
Tizanidine Hcl	80	$594
Cyclobenzaprine Hcl	36	$358
Baclofen	30	$329
Duloxetine Hcl	21	$282
Diclofenac Sodium	24	$201
Methocarbamol	28	$145
Meloxicam	47	$122
Celecoxib	11	$91
Methylprednisolone	18	$88
Cephalexin	21	$83
Tramadol Hcl	14	$56

Paid to pharmacies, not to this prescriber.

Other pain medicine in Schaumburg

David EsparazSchaumburg$8K
Ricardo VallejoBloomington$2.3M
David DickersonEvanston$558K
Thomas DahlbergRockford$218K
Steven CohenChicago$217K
Albert SinghQuincy$212K
Nirav ShahSkokie$137K
Ryan KutaNaperville$114K
Anthony LebarioElgin$87K
Keith SchmidtHoffman Estates$81K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →